Parsippany, New Jersey / Kista, Sweden, July 23, 2024 — Life Science Newswire – SSI Strategy LLC, a global leader in strategic consulting for life sciences, is pleased to announce a partnership with MPS Metalmind AB, an innovator in AI services. This collaboration marks a significant milestone for SSI Strategy, emphasizing commitment to leveraging cutting-edge artificial intelligence to drive innovation and enhance business capabilities.
Through this partnership, SSI Strategy will leverage Metalmind’s advanced capabilities in natural language processing (NLP) and large language models (LLMs) to enhance our service delivery. This will enable us to:
- Efficiently identify potential client organizations that stand to benefit from our market-leading clinical and regulatory skillset.
- Generate high-quality, specialized content and documentation tailored to the unique needs of our clients.
Johan Strömquist, Chief Innovation Officer at SSI Strategy says: “Partnering with Metalmind opens new possibilities for SSI Strategy, enhancing our service offerings and strengthening our market position. This collaboration positions SSI Strategy as a leader in AI-supported consulting services and allows us to scale to meet growing client demands without compromising quality.”
About SSI Strategy LLC
SSI Strategy LLC is a global strategic consulting firm dedicated to supporting the medical office needs of life science organizations. Headquartered in Parsippany, NJ, SSI Strategy helps clients maximize therapeutic value from translational development to product launch, expertly navigating the complexities of bringing important therapeutics to market.
About MPS Metalmind AB
MPS Metalmind AB is a pioneering AI service provider specializing in NLP solutions, knowledge graphs, document generation, and conversational agents. Based in Kista, Sweden, Metalmind is committed to delivering innovative AI technologies that transform business processes and enhance decision-making capabilities.